According to Zhitong Finance App, Hengrui Pharmaceutical (01276) announced that in July 2026, the company repurchased 280,000 shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.004% of the company's total share capital. The highest purchase price was RMB 54.05 per share, the lowest price was RMB 53.75 per share, and the total amount paid was RMB 1,50888 million (not including transaction fees).

As of July 31, 2026, the company's share repurchase plan has accumulated 137.502 million shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.21% of the company's total share capital. The highest price purchased was RMB 70.00 per share, the lowest price was RMB 45.30 per share, and the total amount paid was RMB 853.0848 million (excluding transaction fees).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.